Acesol (Acesol)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substancePotassium chloride + Sodium acetate + Sodium chloridePotassium chloride + Sodium acetate + Sodium chloride
Similar drugsTo uncover
  • Acesol
    solution in / in 
    BIOSINTEZ, PAO     Russia
  • Acesol
    solution in / in 
    MOSFARM, LLC    
  • Acesol
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Acesol
    solution d / infusion 
    Kursk Biofactory - BIOK, FKP     Russia
  • Acesol
    solution d / infusion 
    GROTEKS, LLC     Russia
  • Acesol
    solution d / infusion 
    RESTER, CJSC     Russia
  • Acesol
    solution d / infusion 
    GEMATEK, LLC     Russia
  • Acesol
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Acesol
    solution d / infusion 
    DALHIMFARM, OJSC     Russia
  • Acesol
    solution d / infusion 
    NESVIZH FACTORY OF MEDICAL PREPARATIONS, RUP     Republic of Belarus
  • Chlossol
    solution in / in 
    BIOCHEMIST, OJSC     Russia
  • Chlossol
    solution in / in 
    GROTEKS, LLC     Russia
  • Chlossol
    solution in / in 
    NESVIZH FACTORY OF MEDICAL PREPARATIONS, RUP     Republic of Belarus
    • Dosage form: & nbspsolution for infusions
    Composition:

    Sodium chloride -5 g

    Sodium acetate trihydrate -2 g

    Potassium chloride -1 g

    Excipients:

    Water for injections -up to 1 liter

    Description:

    Transparent colorless liquid.

    Pharmacotherapeutic group:Rehydrating agent
    ATX: & nbsp

    B.05.B.B.01   Electrolytes

    Pharmacodynamics:

    Combined saline solution for rehydration and detoxification. Has a hemodynamic effect, reducing hypovolemia,interfering with blood thickening and development of metabolic acidosis, improves capillary blood circulation, increases diuresis and exerts detoxification effect.

    Pharmacokinetics:

    It is excreted by the kidneys.

    Indications:

    Rehydration, intoxication on the background of dehydration (cholera, acute shigellosis, food poisoning, the presence of contraindications to the introduction of large amounts of liquid into the body.

    Contraindications:

    Hypersensitivity, hyperkalemia, renal and heart failure, alkalosis.

    Carefully:Not described.
    Pregnancy and lactation:

    The use of the drug during pregnancy is possible only if the intended benefit to the mother exceeds the potential risk to the fetus. It should refrain from breastfeeding during the period of use of the drug because of the lack of relevant clinical data.

    Dosing and Administration:

    The drug is used only for moderate and severe conditions when it is not possible to take solutions for oral rehydration.

    Intravenously (struino and drip), under the control of laboratory indicators. Within 1 hour, a solution is introduced in an amount corresponding to 7-10 % of the body weight of the patient, then the jet infusion is replaced by a dropwise addition, for 24-48 hours at a rate of 40-120 cap / min. Before administration, the solution is heated to 36 - 38 ° C. The solution is administered in amounts necessary to restore the volume of fluid lost with feces, vomit, urine, sweat.

    The balance of the injected and lost liquid is determined every 6 hours.

    Side effects:

    Edema, tachycardia, hyperkalemia. In some cases, chills may occur.

    Overdose:

    No reports of overdose cases.

    Interaction:

    When combined with other drugs, it is necessary to visually control the pharmaceutical compatibility.

    Special instructions:

    In general, when dehydration is indicated, administration of solutions is indicated by mouth, and only when this is not possible (for one reason or another) the drug is administered parenterally. Therapy is carried out under the control of hematocrit and the concentration of blood electrolytes. With the development of hyperkalemia, the solution can be replaced with a solution of "Disol" until the electrolyte balance is normalized.

    Effect on the ability to drive transp. cf. and fur:

    It was not reported on the effect of the drug on psychophysiological reactions and the ability to managecar and other mechanisms.

    Form release / dosage:

    Solution for infusion.

    Packaging:

    200 ml or 400 ml in glass bottles for blood, transfusion and infusion preparations.

    1 bottle with instructions for use in a pack of cardboard.

    For 20, 24 or 28 bottles with a capacity of 250 ml or 15 bottles with a capacity of 450 ml with an equal number of instructions for use in a cardboard box with partitions (for hospitals).

    Storage conditions:

    At a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Note. Freezing the drug, provided that the bottle is not leaking, and also the non-wetting of the inner surface of its wall are not grounds for refusing to use it.

    Shelf life:2 years. Do not use after the expiration date indicated on the label.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-002239
    Date of registration:16.04.2012 / 03.09.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:Kursk Biofactory - BIOK, FKPKursk Biofactory - BIOK, FKP Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.10.2017
    Illustrated instructions
      Instructions
      Up